iRhythm Holdings (IRTC) Total Current Liabilities (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Total Current Liabilities came in at $131.8 million in Q1 2026, up 18.33% year-on-year from $111.3 million in Q1 2025, and down 13.26% on a QoQ basis from $151.9 million in Q4 2025.
iRhythm Holdings (IRTC) Total Current Liabilities (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Total Current Liabilities data on file, last reported at $131.8 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 18.33% year-over-year to $131.8 million in Q1 2026; TTM through Mar 2026 was $131.8 million, a 18.33% increase from a year earlier, with the FY2025 full-year figure at $151.9 million, up 36.94% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $131.8 million, down from $151.9 million in the prior quarter.
- Over the last five years, Total Current Liabilities for IRTC reached as high as $151.9 million in Q4 2025 and fell as low as $61.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $103.9 million across 5 years, with a median of $100.1 million in 2024.
- Across the five-year window, Total Current Liabilities fell 3.56% in 2022 and surged 46.76% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $89.1 million in 2022, then grew by 20.51% to $107.4 million in 2023, then climbed by 3.31% to $110.9 million in 2024, then surged by 36.94% to $151.9 million in 2025, then declined by 13.26% to $131.8 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $131.8 million in Q1 2026, $151.9 million in Q4 2025, and $146.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn | 131.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131.75 Mn |
| Dec 31, 2025 | 151.89 Mn |
| Sep 30, 2025 | 146.91 Mn |
| Jun 30, 2025 | 132.21 Mn |
| Mar 31, 2025 | 111.34 Mn |
| Dec 31, 2024 | 110.92 Mn |
| Sep 30, 2024 | 100.10 Mn |
| Jun 30, 2024 | 97.90 Mn |
| Mar 31, 2024 | 96.84 Mn |
| Dec 31, 2023 | 107.37 Mn |
| Sep 30, 2023 | 102.29 Mn |
| Jun 30, 2023 | 89.41 Mn |
| Mar 31, 2023 | 81.90 Mn |
| Dec 31, 2022 | 89.10 Mn |
| Sep 30, 2022 | 83.59 Mn |
| Jun 30, 2022 | 70.42 Mn |
| Mar 31, 2022 | 61.78 Mn |
| Dec 31, 2021 | 87.85 Mn |
| Sep 30, 2021 | 82.78 Mn |
| Jun 30, 2021 | 73.02 Mn |